Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA To Rethink Pre-Market Approval Process For Radiotherapy Devices

This article was originally published in The Gray Sheet

Executive Summary

FDA hopes to reduce dosage errors and misaligned exposures during therapeutic radiation by rethinking pre-market approval strategies for certain radiation therapy devices

You may also be interested in...



New Guidance Will Clarify Which Devices Aren't Eligible For Simpler 510(k)s

Firms that say they've had a harder time getting "special" 510(k) submissions cleared by FDA may benefit from clarifications expected in upcoming agency guidance.

New Guidance Will Clarify Which Devices Aren't Eligible For Simpler 510(k)s

Firms that say they've had a harder time getting "special" 510(k) submissions cleared by FDA may benefit from clarifications expected in upcoming agency guidance.

Industry Unveils Radiation Therapy Patient Protection Effort At FDA Meeting

Manufacturers of linear accelerators and other devices for radiation oncology treatments are endorsing an industry "Radiation Therapy Readiness Check Initiative" to help prevent treatment errors

Related Content

Topics

UsernamePublicRestriction

Register

MT028723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel